Earnings are out
CUVL · NASDAQ · Medical - Pharmaceuticals

Clinuvel Pharmaceuticals (ADR)

Commercializes SCENESSE® for adult EPP and develops melanocortin therapies.

$6.15
After-hours close−0.01 (−0.16%)
At close$6.16(−9.01%)
DateEstimateReportedSurprise
Aug 2026$0.35$0.35−1.0%
Aug 2026$0.35$0.34−3.5%
Report dateEPS estEPSSurpriseRevenue estRevenueSurprise
Aug 27, 2026$0.35$0.35−1.0%$42.2M$43.8M+3.6%
Aug 26, 2026$0.35$0.34−3.5%$42.2M$41.1M−2.8%